NCT06634004
Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya
Enrolling by Invitation
Not specifiedAges 18–69ObservationalVanderbilt University Medical CenterInvestigator-initiated
~100 participants
Updated 2026-01-14 on ClinicalTrials.gov
What's tested:BOLD MRI
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Revascularization success
Measured over 6 years
Conditions
NCT06634004
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Johns Hopkins University
Baltimore, Marylandno site contact published
Vanderbilt University Medical Center
Nashville, Tennesseeno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Manus J Donahue, MBA, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
Both moyamoya and healthy controls
What this trial measures
- Revascularization success6 years
The outcome measure will be the number of patients with successful surgical revascularization.